K. M. Health Care
Ellis Bridge, Ahmedabad, Gujarat
SEND SMS
SEND EMAIL

Ledipasvir 90mg and Sofosbuvir 400mg Tablets

Our product range includes a wide range of velasof, hepcdac 60mg tablet, hepcvel, hepcvir, velpanat and myhep all.

Velasof

Velasof
  • Velasof
Get Best Quote
Approx. Price: Rs 15,500 / Pack

Product Details:

Strength/Dose (in mg or ml)1 Tablet in a day.
Pack Size1*28
Product TypeFinish Product
BrandVelasof

Velasof Tablet
Packing: 1*28 Tablet
Company: Hetero
Contain : Sofosbuir 400mg Velpatasvir 100mg

Velasof Tablet by Hetero contain Sofosbuvir 400mg and Velpatasvir 100mg . Velasof Tablet is generic of EPCLUSA.


Hetero's Velasof Tablet is use for the treatment of Hepatitis C. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

 

There is currently no vaccine for hepatitis C; however research in this area is ongoing.

Dosage:

The recommended dose of Velasof Tablet tablet once daily , taken orally, with or without food .

The recommended dose of Velasof Tablet ( Sofosbuvir + Velpatasvir ) is as below.

The dose of Epclusa In Genotype 1,2,3,4,5,6  without cirrhosis And Patient with compensated cirrhosis is 12 weeks without Ribavarin.

The dose of Velasof Tablet In Genotype 1,2,3,4,5,6 Patient  with decompensated cirrhosis is 12 weeks with Ribavarin

Adverse Reaction:

Most common adverse reactions  observed with Velasof Tablet is headache , Fatigue , Asthenia , Nausea, Headache ,insomnia , diarrhea.

Storage : Velasof should be stored below temperature 30°C.

Side Effect:

Most common side effect with Velasof Tablet  is tiredness , headache , weakness, confusion, memory problems ,

 

Velasof Tablet should be taken on Doctor prescription only.

K M Healthcare is trader , exporter, supplier of Velasof Tablet at very economical price.

Velasof Tablet In India , Hetero Velasof Tablet , Hetero’s Sofosbuvir and Velpatasavir.

Velpatasvir and Sofosbuvir supplier from India,  Velasof exporter Supplier

K M Healthcare Supplier Exporter of Velasof Tablet to the patient and many country. We supply it to county like Russia, Romania, Ukraine, Belarus, Uzbekistan , Cambodia ,  Singapore,China , Minsk , Armenia , Europe Germany , London, Switzerland , France, Denmark, Barcelona, Spain, Austria,   Australia, Africa , Newzeland , Vietnam , Hongkong, Japan,  Australia , Afghanistan , Maldova , Iran, Dubai , Philippines, Thailand , Malaysia ,  Uk , London ,Germany and many more countries and Cities.

Request
Callback
Yes! I am interested

Hepcdac 60mg Tablet

Hepcdac 60mg Tablet
  • Hepcdac 60mg Tablet
Ask For Price

Product Details:

Packaging Size*1*28
Packaging TypeTablet
Dose/Strength (ex. 1 mg or 1 ml)Once in a Day
UsageHospital

Hepcdac :
Packing - 1*28 Tablet
Company - Cipla
contain - Daclatasvir

Hepcdac  is marketed and Manufactured by Cipla Pharmaceuticals LTD. Hepcdac  daclastavir is available as  60mg and 30 mg Tablet  Packing of 28 Pills.  Hepcdac is Generic of Deklinza Of BMS.

Hepcdac  should be taken with doctor prescription only

Hepcdac is a hepatitis C virus (HCV) inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection.

Daclatasvir is an inhibitor of NS5A, a nonstructural protein encoded by HCV. Daclatasvir

binds to the N-terminus of NS5A and inhibits both viral RNA replication and virion assembly.

Dosage:

Hepcdac  contain Daclatasvir 60mg . Hepcdac of Cipla is for the treatment of Hepatitis C.

The recommended dosage of  Hepcdac is 60 mg, taken orally, once daily, with or without food .

For HCV genotype 1 or 3 patients with cirrhosis or post-transplantation patients, the starting dose of ribavirin is 600 mg once daily, increasing up to 1000 mg daily as tolerated. The starting dose and on-treatment dose of ribavirin can be decreased based on hemoglobin and creatinine clearance.

For HCV genotype 3 patients with compensated cirrhosis, the recommended dosing of ribavirin is based on weight 1000 mg for patients weighing less than 75 kg and 1200 mg for those weighing at least 75 kg administered orally in two divided doses with food

 

Adverse Reaction:

Most common adverse reactions  observed with Hepcdac in combination with Hepcinat  were headache and fatigue.

Most common adverse reactions  observed with Daclastavir in combination with

sofosbuvir and ribavirin were headache, anemia, fatigue, and nausea.  

 

Storage : Hepcdac should be stored at room temperature between 20°C and 25°C

 

Side Effects:  Patient should contact to the  physician if get the  side effects on Daclatasvir  treatment like Dizziness , not feeling well ,Tiredness, weakness, Chest Pain , Headache., Anemia,

 

K M healthcare is trader  , Exporter or supplier of  Hepcdac Daclastavir Tablet.

.

KM Healthcare supply Hepatitis C Medicines Daclastavir at very affordable price.

We export Daclastavir (  Hepcdac  ) Tablet to Russia, China, Belarus, Kazakhstan, Ukraine, Georgia ,  Cambodia, Vietnam , China , Armenia , Belarus , Moldova , Tajakistan , Romania , Minsk ,Uzbekistan , Moscow , Kiev, African Countries, Afganiztan ,  Istambul, Uk , Germany , Hongkong , Iran , Itlay,  and many more countries and cities.

 

Request
Callback
Yes! I am interested

Hepcvel

Hepcvel
  • Hepcvel
Ask For Price

Product Details:

Strength/Dose (in mg or ml)Once Daily
Pack Size1*28
Product TypeFinish Product
BrandHepcvel

Hepcvel Tablet
Packing: 1*28 Tablet
Company: Cipla
Contain : Sofosbuir 400mg Velpatasvir 100mg

Hepcvel Tablet by Cipla contain Sofosbuvir 400mg and Velpatasvir 100mg . Hepcvel Tablet is generic of EPCLUSA.


Hepcvel of Natco Tablet is use for the treatment of Hepatitis C. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

 

There is currently no vaccine for hepatitis C; however research in this area is ongoing.

Dosage:

The recommended dose of Velasof Tablet tablet once daily , taken orally, with or without food .

The recommended dose of Velasof Tablet ( Sofosbuvir + Velpatasvir ) is as below.

The dose of Epclusa In Genotype 1,2,3,4,5,6  without cirrhosis And Patient with compensated cirrhosis is 12 weeks without Ribavarin.

The dose of Hepcvel Tablet In Genotype 1,2,3,4,5,6 Patient  with decompensated cirrhosis is 12 weeks with Ribavarin

Adverse Reaction:

Most common adverse reactions  observed with Velasof Tablet is headache , Fatigue , Asthenia , Nausea, Headache ,insomnia , diarrhea.

Storage : Velasof should be stored below temperature 30°C.

Side Effect:

Most common side effect with HepcvelTablet  is tiredness , headache , weakness, confusion, memory problems ,

 

Hepcvel Tablet should be taken on Doctor prescription only.

K M Healthcare is trader , exporter, supplier of Velasof Tablet at very economical price.

Hepcvel Tablet In India , Hetero Velasof Tablet , Hetero’s Sofosbuvir and Velpatasavir.

Velpatasvir and Sofosbuvir supplier from India,  Velasof exporter Supplier

K M Healthcare Supplier Exporter of Hepcvel Tablet to the patient and many country. We supply it to county like Russia, Romania, Ukraine, Belarus, Uzbekistan , Cambodia ,  Singapore,China , Minsk , Armenia , Europe Germany , London, Switzerland , France, Denmark, Barcelona, Spain, Austria,   Australia, Africa , Newzeland , Vietnam , Hongkong, Japan,  Australia , Afghanistan , Maldova , Iran, Dubai , Philippines, Thailand , Malaysia ,  Uk , London ,Germany and many more countries and Cities.

Request
Callback
Yes! I am interested

Hepcvir

Hepcvir
  • Hepcvir
Ask For Price

Product Details:

Strength/Dose (in mg or ml)Once Daily
Product TypeFinish Product
Pack Size1*28

Hepcvir
Packing - 1*28 Tablet
Company – Cipla
contain - Sofosbuvir

Hepcvir  is marketed and Manufactured by Gilead Cipla.  Hepcivir  contain Sofosbuvir 400mg .

 

Sofosbuvir Is indicated for the treament fo Hepatitis C. Hepcivir also can be use for the treatment of HCV HIV coinfections. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
The hepatitis C virus is a blood borne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.


Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.

The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:

 # injecting drug use through the sharing of injection equipment;

 # The reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and the transfusion of unscreened blood and blood products.


Hepcivir Sofosbuvir should be used in combination with ribavirin , Daclastavir, or with pegylated interferon
Sofosbuvir is effective for the treatment of HCV in Genotyp 1 ,Genotype 2 ,Genotype 3 , Genotype 4.
Sofosbuvir and ribavirin therapy for 24 weeks can be considered for patients with genotype 1

HEPCIVIR is a hepatitis C virus (HCV) nucleotide analog NS5B  polymerase inhibitor

Natdac is a hepatitis C virus (HCV) inhibitor indicated for use with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection.

 

Dosage:

The recommended dose of HEPCIVIR  400mg mg tablet once daily , taken orally, with or without food . Ribavarin dose is for the patient less then or equal to 75 kg is 1000mg and more then or equal to 75 kg is 1200mg.

 

Hepcivir in combination with ribavarin for 24weeks can be given to the Genotype 1 Patient who are interferone ineligible.

For genotype 2 patient treatment -naive and treatment experienced without cirrhosis or with compensated cirrhosis Hepcivir And Ribavarin should be gibven for 12 weeks

In Genotype 3 patient Treatment naive and treatment experienced without cirrhosis or with compensated cirrhosis Sofosbuvir  and Ribavarin should be given for 24 weeks

 

Adverse Reaction:

Most common adverse reactions  observed with Sofosbuvir  in combination with Ribavarin is headache and fatigue.

 

Storage : Hepcivir should be stored at room temperature between 20°C and 25°C

 

Side Effect:

The black box warning  of  Hepcivir is Hepatitis B virus reactivation .  Hepatitis B Virus could become active again during or after HCV treatment with Hepcivir.

 

K M healthcare is trader  , Exporter or supplier of  Hepcivir Sofosbuvir Tablet. .

KM Healthcare supply Hepatitis C Medicines Hepivir, Hepcinat, Hepcinat Lp , Myhep, Myhep Lvir at very affordable price.

We export of Sofosbuvir Tablet to Russia, China, Belarus, Kazakhstan, Ukraine, Georgia ,  Cambodia, Vietnam , China , Armenia , Belarus , Moldova , Tajakistan , Romania , Minsk ,Uzbekistan , Moscow , Kiev, African Countries, Afganiztan ,  Istambul, Uk , Germany , Hongkong , Iran , Itlay,  and many more countries and cities.

 

Request
Callback
Yes! I am interested

Velpanat

Velpanat
  • Velpanat
Ask For Price

Velpanat
Packing: 1*28 Tablet
Company: Natco
Contain : Sofosbuir 400mg Velpatasvir 100mg

Velpanat by Natco contain Sofosbuvir 400mg and Velpatasvir 100mg . Velpanat is generic of EPCLUSA.


Natco's Velpanat is use for the treatment of Hepatitis C. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

 

There is currently no vaccine for hepatitis C; however research in this area is ongoing.

The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:

 # injecting drug use through the sharing of injection equipment;

 # The reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and the transfusion of unscreened blood and blood products.

 Velpanat contain Sofosbuvir Velpatasvir . Sofosbuvir is a HCV nucleotide analog NS5B polymerase inhibitor and Velpatasvir is hepatitis C virus NS5A inhibitor . Velpanat is indicated for the treatment of Chronic Hepatitis  genotype 1,2,3,4,5,6 infection.

The Clinical trail of Epclusa (Astral Trail) was conducted.  And the SVR after 12 week was studies in all HCV genotype patient. In the Genotype 1 patient without cirrhosis or with compensated cirrhosis SVR was 98 to 99%.  In Genotype 2 patient SVR was found 99%, In Genotype 3 SVR was 95% And in genotype 4 and 6 SVR was 100% And 95% in Genotype 5.

In Decompensated Cirrhosis after 12week therapy Sofosbuvir + Velpatasvir in combination with Ribavarin SVR was found 94%.

SVR meaning no detectable of HCV virus after 12 week of treatment.

Dosage:

The recommended dose of Velpanat tablet once daily , taken orally, with or without food .

The recommended dose of Velpanat ( Sofosbuvir + Velpatasvir ) is as below.

The dose of Epclusa In Genotype 1,2,3,4,5,6  without cirrhosis And Patient with compensated cirrhosis is 12 weeks without Ribavarin.

The dose of Velpanat In Genotype 1,2,3,4,5,6 Patient  with decompensated cirrhosis is 12 weeks with Ribavarin

Adverse Reaction:

Most common adverse reactions  observed with Velpanat is headache , Fatigue , Asthenia , Nausia, Headache ,insomnia , diarrhea.

Storage : Velpnat should be stored below temperature 30°C.

Side Effect:

Most common side effect with Velpanat  is tiredness , headache , weakness, confusion, memory problems ,

 

Velpanat should be taken on Doctor prescription only.

K M Healthcare is trader , exporter, supplier of Velapnat Tablet at very economical price.

Velpanat In India , Natco Velpanat , Natco’s Sofosbuvir and Velpatasavir.

Velpatasvir and Sofosbuvir supplier from India, Hpecinat Lp Supplier

We are Supplier Exporter of Velpanat to the patient and many country. We supply it to county like Russia, Romania, Ukraine, Belarus, Uzbekistan , Cambodia ,  Singapore,China , Minsk , Armenia , Europe Germany , London, Switzerland , France, Denmark, Barcelona, Spain, Austria,   Australia, Africa , Newzeland , Vietnam , Hongkong, Japan,  Australia , Afghanistan , Maldova , Iran, Dubai , Philippines, Thailand , Malaysia , Indonesia,  Uk , London ,Germany and many more countries and Cities.

Request
Callback


Additional Information:

  • Minimum Order Quantity: 3 Bottle
Yes! I am interested

MyHep All

MyHep All
  • MyHep All
Get Best Quote
Approx. Price: Rs 2 / Unit

Product Details:

Minimum Order Quantity100 Unit
Strength/Dose (in mg or ml)1 tablet in a day
Pack Size1*28
Product TypeFinish Product

MyHepALL is generic of Epclusa.

Contain : Sofosbuvir 400mg And Velpatasvir 100mg

Company : Mylan

MyhepALL Is indicated for the treament fo Hepatitis C.

MyhepAll or Ipclusa should be taken Oncedaily with or without food.
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.

The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:

  • injecting drug use through the sharing of injection equipment;
  • the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
the transfusion of unscreened blood and blood products.

Sofosbuvir should be used in combination with ribavirin or with pegylated interferon and ribavirin
Sofosbuvir is effective for the treatment of HCV in Genotyp 1 ,Genotype 2 ,Genotype 3 , Genotype 4.
Sofosbuvir and ribavirin therapy for 24 weeks can be considered for patients with genotype 1.

MyhepLvir Sofosbuvir + Ledipasvir show the cure rate of 95 to 97 % In Genotype 1 non Cirrhosis Patient. Myhep Lvir or Harvoni can be used in thr treatment of HIV+HCV Coinfections.

Cure rate means there is no detection of HCV virus in the blood 3 month after treatment is complated.

In Clinical Studies Epclusa Sofosbuvir and Valpatasvir Cure rates are 99 % In genotype 2 and 95% In Genotype 3 Patient.

In Genotype 1 and GT4 and GT5 MyhepAll show the cure rate of 97 to 100%

Side effect with ipclusa or Myhepall in patients with decompensated cirrhosis are fatigue, anemia, nausea, headache, insomnia, and diarrhea.

K M Healthcare is supplier of MYHEPALL, Myhep Lvir, Myhep , Ribavarin, Sofosbuvri Daclastavir Combination or Harvoni Sofosbuvir+ Ledipasvir Combination or Ipclusa Sofosbuvir + Valpatasvir Combnation.

We supply the medicine worldwide . We have client in India, Cambodia, Vietnam , Africa, Russia, China , UK , Europe, Canada , Belarus , Ukraine ,Tazakistan, Iran ,Latin America , Hongkong and many more country .
Request
Callback
Yes! I am interested

MyHep LVIR

MyHep LVIR
  • MyHep LVIR
Get Best Quote
Approx. Price: Rs 1 / Pack

MyHep LVIR Tablet

Packing: 1*28 Tablet

Company: Mylan

Contain : Sofosbuir 400mg & Ledipasvir 90mg

Myhep LVIR by Mylan contain Sofosbuvir 400mg and Ledipasvir 90mg .

MYHEP LVIR is use for the treatment of Hepatitis C.

MYHEP LVIR should be taken on Doctor prescription only.

K M Healthcare is trader and supplier of MYHEP LVIR Tablet at very economical price.

MYHEP LVIR In India , MYELAN MYHEPLVIR , MYLAN's Sofosbuvir and Ledipasvir,

Ledipasvir and Sofosbuvir supplier from India, MYHEP LVIR Supplier.

We are supplier of Myhep Lvir To russia ,china, Cambodia, Vietnam , Belarus , Ukraine , Romania, afganistan, Iran, African Country and many more country.

Sofosbuvir Is indicated for the treament fo Hepatitis C.
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.

The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:

  • injecting drug use through the sharing of injection equipment;
  • the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
the transfusion of unscreened blood and blood products.

Sofosbuvir should be used in combination with ribavirin or with pegylated interferon and ribavirin
Sofosbuvir is effective for the treatment of HCV in Genotyp 1 ,Genotype 2 ,Genotype 3 , Genotype 4.
Sofosbuvir and ribavirin therapy for 24 weeks can be considered for patients with genotype 1.

MyhepLvir  Sofosbuvir + Ledipasvir show the cure rate of 95 to 97 % In Genotype 1 non Cirrhosis Patient.  Myhep Lvir or Harvoni can be used in thr treatment of HIV+HCV Coinfections.

Cure rate means there is no detection of HCV virus in the blood 3 month after treatment is complated.

In Clinical Studies Epclusa Sofosbuvir and Valpatasvir Cure rates are 99 % In genotype 2 and 95% In Genotype 3 Patient.

In Genotype 1 and GT4 and GT5 MyhepAll show the cure  rate of 97 to 100%

K M Healthcare is supplier of MYHEPALL, Myhep Lvir, Myhep , Ribavarin, Sofosbuvri & Daclastavir Combination or Harvoni Sofosbuvir+ Ledipasvir Combination or Ipclusa Sofosbuvir + Valpatasvir Combnation.

We supply the medicine worldwide . We have client in India, Cambodia, Vietnam , Africa, Russia, China , UK , Europe, Canada , Belarus , Ukraine ,Tazakistan,  Iran ,Latin America , Hongkong and many more country .
Request
Callback
Yes! I am interested

MyHep Tablet

MyHep Tablet
  • MyHep Tablet
Ask For Price

Product Details:

Minimum Order Quantity1 Bottle
Pack Size1*28
Pack TypeTablet

MyHep Tablet

Packing: 1*28 Tablet

Company: Mylan

Contain : Sofosbuvir 400mg

MyHep contain Sofosbuvir 400mg. Sofosbuvir is use for the treatment of Hepatitis C.

MyHep should be taken on Doctor prescription only.

MyHep is generic of Sovaldi.

We Supply the medicine on the doctor prescription or a Medicine licence holder only.

K M Healthcare is trader and supplier of MyHep Tablet at very economical price.

We are supplier of Myhep  to russia ,china, Cambodia, Vietnam , Belarus , Ukraine , Romania, afganistan, Iran, African Country and many more country.

Request
Callback
Yes! I am interested

Sofab Sofosbuvir 400mg Tablets

Sofab Sofosbuvir 400mg Tablets
  • Sofab Sofosbuvir 400mg Tablets
Ask For Price
Sofab Tablet

Packing: 1*28 Tablet

Company: Ranbaxy

Contain : Sofosbuvir 400mg

Sofab contain Sofosbuvir 400mg. Sofosbuvir is use for the treatment of Hepatitis C.

Sofab should be taken on Doctor prescription only.

K M Healthcare is trader and supplier of Sofab Tablet at very economical price.

Request
Callback
Yes! I am interested

Ledifos Tablet

Ledifos Tablet
  • Ledifos Tablet
Ask For Price
Ledifo Tablet

Packing: 1*28 Tablet

Company: Hetro

Contain : Sofosbuir 400mg & Ledipasvir 90mg

Ledifos by Hetro contain Sofosbuvir 400mg and Ledipasvir 90mg .

Ledifos by Hetro is use for the treatment of Hepatitis C.

Ledifos should be taken on Doctor prescription only.

K M Healthcare is trader and supplier of Ledifos Tablet at very economical price.

Ledifos In India , Hetro Ledifos , Hetro's Sofosbuvir and Ledipasvir,
Ledipasvir and Sofosbuvir supplier from India.

We are suppliying Ledifos to China, Russia , Cambodia, Vietnam and many more country.
Request
Callback


Additional Information:

  • Minimum Order Quantity: 1 Pack(s)
Yes! I am interested

Ledviclear

Ledviclear
  • Ledviclear
Get Best Quote
Approx. Price: Rs 1 / Unit

Product Details:

Packaging Size400 mg
Packaging Type1*28
Dose/Strength (ex. 1 mg or 1 ml)400mg
UsageClinical

Ledviclear Tablet

Packing: 1*28 Tablet

Company: Abbott

Contain : Sofosbuir 400mg & Ledipasvir 90mg

Ledviclear contain Sofosbuvir 400mg and Ledipasvir 90mg .

Ledviclear by Abbott is use for the treatment of Hepatitis C.

Ledviclear should be taken on Doctor prescription only.

K M Healthcare is trader and supplier of Ledviclear Tablet at very economical price.

Ledciclear In India , Abbott Ledviclear , Abbott's Sofosbuvir and Ledipasvir,
Ledipasvir and Sofosbuvir supplier from India. Ledviclear cost in India.

Sofosbuvir Is indicated for the treament fo Hepatitis C.
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.

The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:

  • injecting drug use through the sharing of injection equipment;
  • the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
the transfusion of unscreened blood and blood products.

Sofosbuvir should be used in combination with ribavirin or with pegylated interferon and ribavirin
Sofosbuvir is effective for the treatment of HCV in Genotyp 1 ,Genotype 2 ,Genotype 3 , Genotype 4.
Sofosbuvir and ribavirin therapy for 24 weeks can be considered for patients with genotype 1.

MyhepLvir  Sofosbuvir + Ledipasvir show the cure rate of 95 to 97 % In Genotype 1 non Cirrhosis Patient.  Myhep Lvir or Harvoni can be used in thr treatment of HIV+HCV Coinfections.

Cure rate means there is no detection of HCV virus in the blood 3 month after treatment is complated.

In Clinical Studies Epclusa Sofosbuvir and Valpatasvir Cure rates are 99 % In genotype 2 and 95% In Genotype 3 Patient.

In Genotype 1 and GT4 and GT5 MyhepAll show the cure  rate of 97 to 100%

K M Healthcare is supplier of MYHEPALL, Myhep Lvir, Myhep , Ribavarin, Sofosbuvri & Daclastavir Combination or Harvoni Sofosbuvir+ Ledipasvir Combination or Ipclusa Sofosbuvir + Valpatasvir Combnation.

We supply the medicine worldwide . We have client in India, Cambodia, Vietnam , Africa, Russia, China , UK , Europe, Canada , Belarus , Ukraine ,Tazakistan,  Iran ,Latin America , Hongkong and many more country .
Request
Callback
Yes! I am interested

Ledipasvir 90mg and Sofosbuvir 400mg Tablets

Ledipasvir 90mg and Sofosbuvir 400mg Tablets
  • Ledipasvir 90mg and Sofosbuvir 400mg Tablets
Ask For Price
Ledifo Tablet

Packing: 1*28 Tablet

Company: Hetro

Contain : Sofosbuir 400mg & Ledipasvir 90mg

Ledifos by Hetro contain Sofosbuvir 400mg and Ledipasvir 90mg .

Ledifos by Hetro is use for the treatment of Hepatitis C.

Ledifos should be taken on Doctor prescription only.

K M Healthcare is trader and supplier of Ledifos Tablet at very economical price.

Ledifos In India , Hetro Ledifos , Hetro's Sofosbuvir and Ledipasvir,
Ledipasvir and Sofosbuvir supplier from India.

We supply Ledifos to Cambodia , China and many more country.
Request
Callback
Yes! I am interested

Sofocure 400mg Tablet

Sofocure 400mg Tablet
  • Sofocure 400mg Tablet
Get Best Quote
Approx. Price: Rs 2 / Unit

Product Details:

Strength/Dose (in mg or ml)400 mg
Pack Size1*28
Product TypeFinish Product
BrandSofocure

Sofocure Tablet

Packing: 1*28 Tablet

Company: Emcure

Contain : Sofosbuvir 400mg

Sofocure contain Sofosbuvir 400mg. Sofosbuvir is use for the treatment of Hepatitis C.

Sofocure should be taken on Doctor prescription only.

K M Healthcare is trader and supplier of Sofocure Tablet at very economical price.

Sofosbuvir Is indicated for the treament fo Hepatitis C.
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.

The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:

  • injecting drug use through the sharing of injection equipment;
  • the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
the transfusion of unscreened blood and blood products.

Sofosbuvir should be used in combination with ribavirin or with pegylated interferon and ribavirin
Sofosbuvir is effective for the treatment of HCV in Genotyp 1 ,Genotype 2 ,Genotype 3 , Genotype 4.
Sofosbuvir and ribavirin therapy for 24 weeks can be considered for patients with genotype 1.

MyhepLvir  Sofosbuvir + Ledipasvir show the cure rate of 95 to 97 % In Genotype 1 non Cirrhosis Patient.  Myhep Lvir or Harvoni can be used in thr treatment of HIV+HCV Coinfections.

Cure rate means there is no detection of HCV virus in the blood 3 month after treatment is complated.

In Clinical Studies Epclusa Sofosbuvir and Valpatasvir Cure rates are 99 % In genotype 2 and 95% In Genotype 3 Patient.

In Genotype 1 and GT4 and GT5 MyhepAll show the cure  rate of 97 to 100%

K M Healthcare is supplier of MYHEPALL, Myhep Lvir, Myhep , Ribavarin, Sofosbuvri & Daclastavir Combination or Harvoni Sofosbuvir+ Ledipasvir Combination or Ipclusa Sofosbuvir + Valpatasvir Combnation.

We supply the medicine worldwide . We have client in India, Cambodia, Vietnam , Africa, Russia, China , UK , Europe, Canada , Belarus , Ukraine ,Tazakistan,  Iran ,Latin America , Hongkong and many more country .
Request
Callback
Yes! I am interested

Dacla Hep Hetro Medicine

Dacla Hep Hetro Medicine
  • Dacla Hep Hetro Medicine
Get Best Quote
Approx. Price: Rs 2 / Box

Product Details:

Minimum Order Quantity50 Box
Packaging Size1*28
Packaging TypeTablet
Dose/Strength (ex. 1 mg or 1 ml)400mg
UsageClinical, Hospital, Personal

DaclaHep

Packing - 1*28 Tablet

Company - Hetro

contain - Daclatasvir

DaclaHep contain Daclatasvir 60mg . DaclaHep is for the treatment of Hepatitis C.

DaclaHep should be taken with doctor prescriptin only.

K M healthcare is trader or supplier of DaclaHep Tablet.

We supply the medicine on the doctor presription or to the medicine license holder only.

Sofosbuvir Is indicated for the treament fo Hepatitis C.
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.

The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:

  • injecting drug use through the sharing of injection equipment;
  • the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
the transfusion of unscreened blood and blood products.

Sofosbuvir should be used in combination with ribavirin or with pegylated interferon and ribavirin
Sofosbuvir is effective for the treatment of HCV in Genotyp 1 ,Genotype 2 ,Genotype 3 , Genotype 4.
Sofosbuvir and ribavirin therapy for 24 weeks can be considered for patients with genotype 1.

MyhepLvir  Sofosbuvir + Ledipasvir show the cure rate of 95 to 97 % In Genotype 1 non Cirrhosis Patient.  Myhep Lvir or Harvoni can be used in thr treatment of HIV+HCV Coinfections.

Cure rate means there is no detection of HCV virus in the blood 3 month after treatment is complated.

In Clinical Studies Epclusa Sofosbuvir and Valpatasvir Cure rates are 99 % In genotype 2 and 95% In Genotype 3 Patient.

In Genotype 1 and GT4 and GT5 MyhepAll show the cure  rate of 97 to 100%

K M Healthcare is supplier of MYHEPALL, Myhep Lvir, Myhep , Ribavarin, Sofosbuvri & Daclastavir Combination or Harvoni Sofosbuvir+ Ledipasvir Combination or Ipclusa Sofosbuvir + Valpatasvir Combnation.

We supply the medicine worldwide . We have client in India, Cambodia, Vietnam , Africa, Russia, China , UK , Europe, Canada , Belarus , Ukraine ,Tazakistan,  Iran ,Latin America , Hongkong and many more country .
Request
Callback
Yes! I am interested

Hepcinat LP

Hepcinat LP
  • Hepcinat LP
Get Best Quote
Approx. Price: Rs 1 / Pack

Product Details:

Minimum Order Quantity100 Pack
Dose/Strength (mg or ml)400 mg
Pack Size1*28
Pack TypeTablet

Hepcinat Lp

   Hepcinat Lp is marketed By Natco a, Hepcinat Lp Contain Sofosbuvir and Ledipasvir For the treatment of Hepatitis C.

Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.

The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:

  • injecting drug use through the sharing of injection equipment;
  • the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
the transfusion of unscreened blood and blood products.

Sofosbuvir should be used in combination with ribavirin or with pegylated interferon and ribavirin
Sofosbuvir is effective for the treatment of HCV in Genotyp 1 ,Genotype 2 ,Genotype 3 , Genotype 4.
Sofosbuvir and ribavirin therapy for 24 weeks can be considered for patients with genotype 1.

MyhepLvir  Sofosbuvir + Ledipasvir show the cure rate of 95 to 97 % In Genotype 1 non Cirrhosis Patient.  Myhep Lvir or Harvoni can be used in thr treatment of HIV+HCV Coinfections.

Cure rate means there is no detection of HCV virus in the blood 3 month after treatment is complated.

In Clinical Studies Epclusa Sofosbuvir and Valpatasvir Cure rates are 99 % In genotype 2 and 95% In Genotype 3 Patient.

In Genotype 1 and GT4 and GT5 MyhepAll show the cure  rate of 97 to 100%

K M Healthcare is supplier of Valpanat, Hepcinat Lp , Hepcinat , Natdac , Ribavarin, Sofosbuvri & Daclastavir Combination or Harvoni (Gilead) Sofosbuvir+ Ledipasvir Combination or Ipclusa (Gilead Lifescience) Sofosbuvir + Valpatasvir Combnation.

Hepciant Lp is a generic of Harvoni.

We supply the medicine worldwide . We have client in India, Cambodia, Vietnam , Africa, Russia, China , UK , Europe, Canada , Belarus , Ukraine ,Tazakistan,  Iran ,Latin America , Hongkong and many more country .
Request
Callback
Yes! I am interested

Ledifos Tablet

Ledifos Tablet
  • Ledifos Tablet
Ask For Price

Product Details:

Dose/Strength (mg or ml)400mg
Pack Size1*28
Pack TypeBottle

Ledifos

Packing: 1*28 Tablet

Company: Hetro

Contain : Sofosbuir 400mg & Ledipasvir 90mg

Ledifos contain Sofosbuvir 400mg and Ledipasvir 90mg .

Ledifos is use for the treatment of Hepatitis C.

Ledifos should be taken on Doctor prescription only.

K M Healthcare is trader and supplier of Ledifos Tablet at very economical price.

Ledifos in India, Hetro Ledifos, Ledifos by Hetro.

Sofosbuvir Is indicated for the treament fo Hepatitis C.
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.

The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:

  • injecting drug use through the sharing of injection equipment;
  • the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
the transfusion of unscreened blood and blood products.

Sofosbuvir should be used in combination with ribavirin or with pegylated interferon and ribavirin
Sofosbuvir is effective for the treatment of HCV in Genotyp 1 ,Genotype 2 ,Genotype 3 , Genotype 4.
Sofosbuvir and ribavirin therapy for 24 weeks can be considered for patients with genotype 1.

MyhepLvir  Sofosbuvir + Ledipasvir show the cure rate of 95 to 97 % In Genotype 1 non Cirrhosis Patient.  Myhep Lvir or Harvoni can be used in thr treatment of HIV+HCV Coinfections.

Cure rate means there is no detection of HCV virus in the blood 3 month after treatment is complated.

In Clinical Studies Epclusa Sofosbuvir and Valpatasvir Cure rates are 99 % In genotype 2 and 95% In Genotype 3 Patient.

In Genotype 1 and GT4 and GT5 MyhepAll show the cure  rate of 97 to 100%

K M Healthcare is supplier of MYHEPALL, Myhep Lvir, Myhep , Ribavarin, Sofosbuvri & Daclastavir Combination or Harvoni Sofosbuvir+ Ledipasvir Combination or Ipclusa Sofosbuvir + Valpatasvir Combnation.

We supply the medicine worldwide . We have client in India, Cambodia, Vietnam , Africa, Russia, China , UK , Europe, Canada , Belarus , Ukraine ,Tazakistan,  Iran ,Latin America , Hongkong and many more country .
Request
Callback
Yes! I am interested

Hepcinat Tablet

Hepcinat Tablet
  • Hepcinat Tablet
Get Best Quote
Approx. Price: Rs 1 / Bottle(s)
Hepcinat Tablet

Packing: 1*28 Tablet

Company: Natco

Contain : Sofosbuir 400mg

Hepcinat by Natco contain Sofosbuvir 400mg. Natco's Sofosbuvir is use for the treatment of Hepatitis C.

Hepcinat should be taken on Doctor prescription only.

K M Healthcare is trader and supplier of Hepcinat Tablet at very economical price.

Hepcinat In India , Natco Hepcinat , Natco Sofosbuvir, Sofosbuvir by Natco, Sofosbuvir In India.

We are supplying Hepcinat 400mg to Russia, China, Cambodia, Vietnam and many more country.
Request
Callback
Yes! I am interested

Hepcinat LP Tablet

Hepcinat LP Tablet
  • Hepcinat LP Tablet
Ask For Price

Product Details:

Product TypeFinished Product
Dose400 mg
UsageHospital
Packaging Size1*28
Packaging TypeTablets

Hepcinat LP Tablet

Packing: 1*28 Tablet

Company: Natco

Contain  : Sofosbuir 400mg & Ledipasvir 90mg

Hepcinat Lpby Natco contain Sofosbuvir 400mg and Ledipasvir 90mg .

Natco's Hepcinat Lp is use for the treatment of Hepatitis C.


Hepcinat LP should be taken on Doctor prescription only.

K M Healthcare is trader and supplier of Hepcinat Lp Tablet at very economical price.

Hepcinat Lp In India , Natco Hepcinat Lp , Natoc's  Sofosbuvir and Ledipasvir,

Ledipasvir and Sofosbuvir supplier from India, Hpecinat Lp Supplier.
Request
Callback
Yes! I am interested

Sofosbuvir

Sofosbuvir
  • Sofosbuvir
Get Best Quote
Approx. Price: Rs 1 / Pack

Product Details:

Minimum Order Quantity20 Pack
Strength/Dose (in mg or ml)400mg
Pack Size28 tablet
Product TypeFinish Product

Sofosbuvir Is indicated for the treament fo Hepatitis C.
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.

The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:

  • injecting drug use through the sharing of injection equipment;
  • the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
the transfusion of unscreened blood and blood products.

Sofosbuvir should be used in combination with ribavirin or with pegylated interferon and ribavirin
Sofosbuvir is effective for the treatment of HCV in Genotyp 1 ,Genotype 2 ,Genotype 3 , Genotype 4.
Sofosbuvir and ribavirin therapy for 24 weeks can be considered for patients with genotype 1.

MyhepLvir Sofosbuvir + Ledipasvir show the cure rate of 95 to 97 % In Genotype 1 non Cirrhosis Patient. Myhep Lvir or Harvoni can be used in thr treatment of HIV+HCV Coinfections.

Cure rate means there is no detection of HCV virus in the blood 3 month after treatment is complated.

In Clinical Studies Epclusa Sofosbuvir and Valpatasvir Cure rates are 99 % In genotype 2 and 95% In Genotype 3 Patient.

In Genotype 1 and GT4 and GT5 MyhepAll show the cure rate of 97 to 100%

K M Healthcare is supplier of MYHEPALL, Myhep Lvir, Myhep , Ribavarin, Sofosbuvri & Daclastavir Combination or Harvoni Sofosbuvir+ Ledipasvir Combination or Ipclusa Sofosbuvir + Valpatasvir Combnation.

We supply the medicine worldwide . We have client in India, Cambodia, Vietnam , Africa, Russia, China , UK , Europe, Canada , Belarus , Ukraine ,Tazakistan, Iran ,Latin America , Hongkong and many more country .
Request
Callback
Yes! I am interested

Mydekla 60 Mg

Mydekla 60 Mg
  • Mydekla 60 Mg
Get Best Quote
Approx. Price: Rs 2 / Box

Product Details:

Minimum Order Quantity200 Box
Packaging Size1*28
Packaging TypeTablet
Dose/Strength (ex. 1 mg or 1 ml)60 ,mg
UsageHospital

Mydekla 60 mg Tablet

Packing: 1*28 Tablet

Company: Mylan

Contain : Daclastavir 60mg

Mydekla by Natco contain Daclastavir 60mg .

Mylan's Mydekla is use for the treatment of Hepatitis C. along with the Sofosbuvir.

Mydekla should be taken on Doctor prescription only.

K M Healthcare is trader and supplier of Mydekla Tablet at very economical price.

We Supply Mydekla in Cambodia, Africa, Romania, Vietnam , Afganistan, Russia and many more countries.
Request
Callback
Yes! I am interested

Velpatasvir 100mg Tablet

Velpatasvir 100mg Tablet
  • Velpatasvir 100mg Tablet
Get Best Quote
Approx. Price: Rs 1.5 / Bottle

Product Details:

Minimum Order Quantity3 Bottle
Packaging Size1*28
Packaging TypeTablet
Dose/Strength (ex. 1 mg or 1 ml)1 tablet in a day
UsageHospital

Velpanat
Packing: 1*28 Tablet
Company: Natco
Contain : Sofosbuir 400mg Velpatasvir 100mg

Velpanat by Natco contain Sofosbuvir 400mg and Velpatasvir 100mg . Velpanat is generic of EPCLUSA.


Natco's Velpanat is use for the treatment of Hepatitis C. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

 

There is currently no vaccine for hepatitis C; however research in this area is ongoing.

The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:

 # injecting drug use through the sharing of injection equipment;

 # The reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and the transfusion of unscreened blood and blood products.

 Velpanat contain Sofosbuvir Velpatasvir . Sofosbuvir is a HCV nucleotide analog NS5B polymerase inhibitor and Velpatasvir is hepatitis C virus NS5A inhibitor . Velpanat is indicated for the treatment of Chronic Hepatitis  genotype 1,2,3,4,5,6 infection.

The Clinical trail of Epclusa (Astral Trail) was conducted.  And the SVR after 12 week was studies in all HCV genotype patient. In the Genotype 1 patient without cirrhosis or with compensated cirrhosis SVR was 98 to 99%.  In Genotype 2 patient SVR was found 99%, In Genotype 3 SVR was 95% And in genotype 4 and 6 SVR was 100% And 95% in Genotype 5.

In Decompensated Cirrhosis after 12week therapy Sofosbuvir + Velpatasvir in combination with Ribavarin SVR was found 94%.

SVR meaning no detectable of HCV virus after 12 week of treatment.

Dosage:

The recommended dose of Velpanat tablet once daily , taken orally, with or without food .

The recommended dose of Velpanat ( Sofosbuvir + Velpatasvir ) is as below.

The dose of Epclusa In Genotype 1,2,3,4,5,6  without cirrhosis And Patient with compensated cirrhosis is 12 weeks without Ribavarin.

The dose of Velpanat In Genotype 1,2,3,4,5,6 Patient  with decompensated cirrhosis is 12 weeks with Ribavarin

Adverse Reaction:

Most common adverse reactions  observed with Velpanat is headache , Fatigue , Asthenia , Nausia, Headache ,insomnia , diarrhea.

Storage : Velpnat should be stored below temperature 30°C.

Side Effect:

Most common side effect with Velpanat  is tiredness , headache , weakness, confusion, memory problems ,

 

Velpanat should be taken on Doctor prescription only.

K M Healthcare is trader , exporter, supplier of Velapnat Tablet at very economical price.

Velpanat In India , Natco Velpanat , Natco’s Sofosbuvir and Velpatasavir.

Velpatasvir and Sofosbuvir supplier from India, Hpecinat Lp Supplier

We are Supplier Exporter of Velpanat to the patient and many country. We supply it to county like Russia, Romania, Ukraine, Belarus, Uzbekistan , Cambodia ,  Singapore,China , Minsk , Armenia , Europe Germany , London, Switzerland , France, Denmark, Barcelona, Spain, Austria,   Australia, Africa , Newzeland , Vietnam , Hongkong, Japan,  Australia , Afghanistan , Maldova , Iran, Dubai , Philippines, Thailand , Malaysia , Indonesia,  Uk , London ,Germany and many more countries and Cities.

Request
Callback
Yes! I am interested
X
Looking for “Ledipasvir 90mg and Sofosbuvir 400mg Tablets”?


Reach Us
Mansukh Bhai Koshti (Proprietor)
6, Thirthraj B, Madalpur, Ellisbridge Opposite V.S. Hospital
Ahmedabad- 380006, Gujarat, India


Call Us

Send E-mail

Send SMS